BIOA B — BioArctic AB Income Statement
0.000.00%
Last trade - 00:00- SEK27.12bn
- SEK24.98bn
- SEK2.00bn
Annual income statement for BioArctic AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.1 | 228 | 616 | 257 | 1,999 |
| Cost of Revenue | |||||
| Gross Profit | -1.71 | 195 | 565 | 230 | 1,940 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 163 | 246 | 363 | 486 | 740 |
| Operating Profit | -140 | -17.3 | 253 | -229 | 1,259 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -141 | -11.2 | 276 | -190 | 1,256 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -120 | -11.2 | 229 | -177 | 1,022 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -120 | -11.2 | 229 | -177 | 1,022 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -120 | -11.2 | 229 | -177 | 1,022 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.36 | -0.13 | 2.59 | -2 | 11.5 |
| Dividends per Share |